Sidra Medicine to Open the First Reprogrammable Cell Therapy Facility in the MENA Region

Sidra Medicine will open the MENA region’s first reprogrammable cell therapy facility as part of its state-of-the-art hospital and research center. ...

Continue Reading

Sidra Medicine’s Chief Research Officer collaborates with internationally-renowned scientists to carry out research with the potential to pave the way for new cancer therapies

A group of scientists including Sidra Medicine’s Chief Research Officer, Dr. Francesco M. Marincola, has discovered that a gene called Bach2 may play ...

Continue Reading